<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Reviewing Challenges in the Diagnosis and Treatment of Lentigo Maligna and Lentigo-Maligna Melanoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Reviewing Challenges in the Diagnosis and Treatment of Lentigo Maligna and Lentigo-Maligna Melanoma." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837936/bin/40487_2015_12_Fig2_HTML.jpg"/> </div> <div class="text-side"> <h1>Reviewing Challenges in the Diagnosis and Treatment of Lentigo Maligna and Lentigo-Maligna Melanoma.</h1> <p>sAC staining of a lentigo maligna melanoma from the face of a 64-year-old woman. a H&amp;E staining at ×20; b H&amp;E staining at ×40; c sAC staining at ×40; d sAC staining at ×100. sAC is a novel marker that is expressed in a pan-nuclear pattern in LM and LMM lesions. The detection with antibody R21 has an estimated sensitivity of 88 % and therefore can be used to determine the margins of the LM/LMM down to a single cell. Although this immunohistochemical stain is very promising, sAC is not yet widely used in dermatopathology labs due to its limited availability. H&amp;E hematoxylin and eosin, LM lentigo maligna, LMM lentigo-maligna melanoma, sAC soluble adenylyl cyclase</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27182482/" target="_blank">27182482</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>